Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 168   

Articles published

GSK 1,492.50 0.00 (0.00%)
price chart
Why British American Tobacco plc Plus GlaxoSmithKline plc Equals Income ...
With yields of 3.8% and 5.4% respectively, British American Tobacco and GlaxoSmithKline combine to offer an average yield of 4.6%.
Why You Should � And Shouldn't � Buy GlaxoSmithKline plc
GlaxoSmithKline, like the rest of the pharmaceuticals sector, has seen revenues growth smashed in recent years as patent losses across key products have relentlessly stacked up.
Why I'm Selling GlaxoSmithKline plc And Buying Shire PLC
Finding a company that has the perfect blend of both growth and income is a difficult game to play. However, it looks as if Shire (LSE: SHP) could be the perfect pick.
Pfizer Inc. Has AstraZeneca plc Or GlaxoSmithKline plc In Its Sights
Pfizer Inc., the world's largest pharmaceutical company, is struggling to find growth. Just like many of its peers, the company is suffering as sales of legacy drugs slide due to the loss of exclusive manufacturing rights.
Is GlaxoSmithKline plc's Dividend About To Be Cut?
Over the last four years, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has increased dividends per share at an annualised rate of 5.4%.
Recent Analysts' Ratings Updates for GlaxoSmithKline plc (GSK)  Dakota Financial News
GlaxoSmithKline plc Stock Rating Lowered by New Street Research (GSK)  WKRB News
Profit From 2015's Dividend Bonanza With GlaxoSmithKline plc, Royal Dutch ...
At present Glaxo offers a regular dividend of around 80p per share, a yield of 5.7%, an impressive figure that you'd be hard pressed to find elsewhere.
JPMorgan Chase & Co. Reaffirms Underweight Rating for GlaxoSmithKline plc ...
Analysts at Berenberg Bank raised their price target on shares of GlaxoSmithKline plc from GBX 1,540 ($23.11) to GBX 1,620 ($24.31) and gave the company a hold rating in a research note on Friday, January 23rd.
How GlaxoSmithKline PLC And AstraZeneca PLC Will Fare In 2015
If you were to ask investors at the beginning of the year whether you should invest in GlaxoSmithKline (LSE: GSK) or AstraZeneca (LSE: AZN), I think most would have picked the former rather than the latter.
Related articles »  
J Sainsbury plc Is Digging Its Own Grave, But GlaxoSmithKline plc Is Looking ...
If you're like me, and you're cautious with your money, you'll have had a good hard look at some of the FTSE 100's best 'defensive' stock offerings over the past 12 months.
Why I Think Shire plc Will Outperform AstraZeneca plc And GlaxoSmithKline plc ...
You probably know everything about GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) by now: a bribery scandal in China, falling earnings and a patent cliff have all weighed on its equity valuation in recent times.